Cargando…

Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis

Background: Human albumin (HA) infusion is potentially effective for the management of hyponatremia in liver cirrhosis, but the current evidence is very limited. Methods: In this retrospective study, 2414 cirrhotic patients who were consecutively admitted to our hospital between January 2010 and Jun...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Zhaohui, Xu, Wentao, Chai, Lu, Zheng, Xiaojie, Méndez-Sánchez, Nahum, Philips, Cyriac Abby, Cheng, Gang, Qi, Xingshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821044/
https://www.ncbi.nlm.nih.gov/pubmed/36614908
http://dx.doi.org/10.3390/jcm12010107
_version_ 1784865604249845760
author Bai, Zhaohui
Xu, Wentao
Chai, Lu
Zheng, Xiaojie
Méndez-Sánchez, Nahum
Philips, Cyriac Abby
Cheng, Gang
Qi, Xingshun
author_facet Bai, Zhaohui
Xu, Wentao
Chai, Lu
Zheng, Xiaojie
Méndez-Sánchez, Nahum
Philips, Cyriac Abby
Cheng, Gang
Qi, Xingshun
author_sort Bai, Zhaohui
collection PubMed
description Background: Human albumin (HA) infusion is potentially effective for the management of hyponatremia in liver cirrhosis, but the current evidence is very limited. Methods: In this retrospective study, 2414 cirrhotic patients who were consecutively admitted to our hospital between January 2010 and June 2014 were included in the Hospitalization outcome cohort, and 339 cirrhotic patients without malignancy who were consecutively admitted to our department between December 2014 and April 2021 were included in the Long-term outcome cohort. The development and improvement of hyponatremia were compared between patients who received HA infusion during hospitalizations and did not. Logistic and Cox regression analyses were performed to evaluate the association of development and improvement of hyponatremia during hospitalizations with the outcomes. Odds ratios (ORs) and hazard ratios (HRs) were calculated. Results: In the two cohorts, HA infusion significantly decreased the incidence of hyponatremia and increased the rate of improvement of hyponatremia in cirrhotic patients during hospitalizations. In the Hospitalization outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with increased in-hospital mortality (OR = 2.493, p < 0.001), and the improvement of hyponatremia during hospitalizations was significantly associated with decreased in-hospital mortality (OR = 0.599, p = 0.014). In the Long-term outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with decreased long-term survival (HR = 0.400, p < 0.001), and the improvement of hyponatremia during hospitalizations was not significantly associated with long-term survival (HR = 1.085, p = 0.813). Conclusions: HA infusion can effectively prevent the development of hyponatremia and improve hyponatremia in cirrhotic patients during hospitalizations, which may influence the patients’ outcomes.
format Online
Article
Text
id pubmed-9821044
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98210442023-01-07 Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis Bai, Zhaohui Xu, Wentao Chai, Lu Zheng, Xiaojie Méndez-Sánchez, Nahum Philips, Cyriac Abby Cheng, Gang Qi, Xingshun J Clin Med Article Background: Human albumin (HA) infusion is potentially effective for the management of hyponatremia in liver cirrhosis, but the current evidence is very limited. Methods: In this retrospective study, 2414 cirrhotic patients who were consecutively admitted to our hospital between January 2010 and June 2014 were included in the Hospitalization outcome cohort, and 339 cirrhotic patients without malignancy who were consecutively admitted to our department between December 2014 and April 2021 were included in the Long-term outcome cohort. The development and improvement of hyponatremia were compared between patients who received HA infusion during hospitalizations and did not. Logistic and Cox regression analyses were performed to evaluate the association of development and improvement of hyponatremia during hospitalizations with the outcomes. Odds ratios (ORs) and hazard ratios (HRs) were calculated. Results: In the two cohorts, HA infusion significantly decreased the incidence of hyponatremia and increased the rate of improvement of hyponatremia in cirrhotic patients during hospitalizations. In the Hospitalization outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with increased in-hospital mortality (OR = 2.493, p < 0.001), and the improvement of hyponatremia during hospitalizations was significantly associated with decreased in-hospital mortality (OR = 0.599, p = 0.014). In the Long-term outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with decreased long-term survival (HR = 0.400, p < 0.001), and the improvement of hyponatremia during hospitalizations was not significantly associated with long-term survival (HR = 1.085, p = 0.813). Conclusions: HA infusion can effectively prevent the development of hyponatremia and improve hyponatremia in cirrhotic patients during hospitalizations, which may influence the patients’ outcomes. MDPI 2022-12-23 /pmc/articles/PMC9821044/ /pubmed/36614908 http://dx.doi.org/10.3390/jcm12010107 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bai, Zhaohui
Xu, Wentao
Chai, Lu
Zheng, Xiaojie
Méndez-Sánchez, Nahum
Philips, Cyriac Abby
Cheng, Gang
Qi, Xingshun
Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
title Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
title_full Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
title_fullStr Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
title_full_unstemmed Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
title_short Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
title_sort effects of short-term human albumin infusion for the prevention and treatment of hyponatremia in patients with liver cirrhosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821044/
https://www.ncbi.nlm.nih.gov/pubmed/36614908
http://dx.doi.org/10.3390/jcm12010107
work_keys_str_mv AT baizhaohui effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis
AT xuwentao effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis
AT chailu effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis
AT zhengxiaojie effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis
AT mendezsancheznahum effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis
AT philipscyriacabby effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis
AT chenggang effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis
AT qixingshun effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis